JP Morgan Chase
RGNX icon

JP Morgan Chase’s Regenxbio RGNX Stock Holding History

JP Morgan Chase’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,400
Closed -$513K – 5852
2019
Q3 		$513K Buy
+14,400
New +$583K ﹤0.01% 4161
2018
Q2 		– Sell
-10,500
Closed -$313K – 5667
2018
Q1 		$313K Sell
10,500
-36,200
-78% -$1.05M ﹤0.01% 4203
2017
Q4 		$1.55M Buy
+46,700
New +$1.41M ﹤0.01% 3469

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

JP Morgan Chase's RGNX Position: Q1 2026 in Review

JP Morgan Chase reduced its Regenxbio (RGNX) stake by 2% in Q1 2026, selling an estimated $732K and leaving 3,483,800 shares worth $27.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1832.

JP Morgan Chase first reported a position in RGNX in Q3 2015 and has held it in 43 quarters since. The position peaked at $174M in Q3 2021. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • JP Morgan Chase held 3,483,800 shares of Regenxbio worth $27.1M as of Q1 2026.
  • JP Morgan Chase sold 69,702 Regenxbio shares in Q1 2026, an estimated $732K.
  • Regenxbio made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1832 holding.
  • JP Morgan Chase first reported a position in Regenxbio in Q3 2015 and has held it in 43 quarters since.
  • JP Morgan Chase's Regenxbio position peaked at $174M in Q3 2021.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.